Cholelithiasis

Abstract

Get full access to this article

View all access options for this article.

References

Morrow

Thompson

Wilson

. Acute cholecystitis in the elderly. Arch Surg 1978; 113: 1149–52.

Way

Sleisenger

. Cholelithiasis and chronic cholecystitis. In: Sleisenger

Fordtran

, eds. Gastrointestinal disease. Philadelphia: WB Saunders, 1978: 1294–313.

Fitzpatrick

Neutra

Gilbert

. Cost-effectiveness of cholecystectomy for silent gallstones. In: Bunker

Barnes

Mosteller

, eds. Costs, risks and benefits of surgery. New York: Oxford University Press, 1977: 246–61.

Robertson

. Silent gallstones. Gastroenterology 1945; 5: 345–71.

Ransohoff

Gracie

Wolfenson

Neuhauser

. Prophylactic cholecstectomy or expectant management for silent gallstones. Ann Intern Med 1983; 99: 199–204.

Hoffman

. The medical treatment of cholesterol gallstones. Am J Med 1980; 69: 4–7.

Burhenne

. Nonoperative retained biliary tract stone extraction. Am J Roentgenol 1973; 177: 388–99.

Glenn

. Postcholecystectomy choledocholithiasis. Surg Gynecol Obstet 1972; 134: 245–52.

Girard

Legros

. Retained and recurrent bile duct stones. Ann Surg 1981; 193: 150–4.

10.

Heiss

Ross

Scholz

Shea

Braasch

. Common bile duct calculi, parts 1 and 2. Postgrad Med 1984; 75: 88–104, 109–17.

11.

Mason

. Percutaneous extraction of retained gallstones via the t-tube tract— British experience of 131 cases. Clin Radiol 1980; 31: 497–9.

12.

Thistle

Carlson

Hofmann

. Monooctanoin a dissolution agent for retained cholesterol bile duct stones. Gastroenterology 1980; 78: 1016–22.

13.

Hofmann

. Chemical dissolution of bile duct stone. World J Surg 1978; 2: 433–7.

14.

Hussar

. New drugs of 85. Am Pharm 1986; NS26: 180–215.

15.

Abate

Moore

. Monooctanoin use for gallstone dissolution. Drug Intell Clin Pharm 1985; 19: 708–13.

16.

Allen

Borody

Bugliosi

May

LaRusso

Thistle

. Rapid dissolution of gallstones by methyl tert-butyl ether. N Engl J Med 1985; 312: 217–20.

17.

Allen

Borody

Bugliosi

May

LaRusso

Thistle

. Cholelitholysis using methyl tertiary butyl ether. Gastroenterology 1985; 88: 122–5.

18.

Little

Dale

Whatley

. Methyl tert-butyl ether, a new chromatographic eluent. J Chromatogr 1979; 169: 381–5.

19.

Rewbridge

. The disappearance of gallstone shadows following the prolonged administration of bile salts. Surgery 1937; 1: 395–400.

20.

Thistle

Schoenfield

. Induced alteration of bile composition in humans with cholelithiasis. Clin Med 1969; 74: 1020–1.

21.

Council on Scientific Affairs. Pharmaceutical dissolution of gallstones. JAMA 1983; 250: 2373–4.

22.

Maton

Iser

Reuben

Saxton

Murphy

Dowling

. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Medicine 1982; 61: 86–97.

23.

Zak

Marks

Schoenfield

. Therapy of cholesterol gallstones. Semin Liver Dis 1983; 3: 132–45.

24.

Schoenfield

Lachin

. Chenodiol for dissolution of gallstones: The National Cooperative Gallstone Study. Ann Intern Med 1981; 95: 257–82.

25.

Iser

Sali

. Chenodeoxycholic acid: A review of its pharmacological properties and therapeutic use. Drugs 1981; 21: 90–119.

26.

Anderson

. Chenodeoxycholic acid desaturates bile—but how? Gastroenterology 1979; 77: 1146–51.

27.

LaRusso

Thistle

. Effect of litholytic bile acids on cholesterol absorption in gallstone patients. Gastroenterology 1983; 84: 265–71.

28.

Product information. Chenix. Baudette, MN: Rowell Laboratories, Inc., 1983.

29.

Danzinger

Hoffman

Schoenfield

. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1971; 286: 1–8.

30.

Bell

Whitney

Dowling

. Gallstone dissolution in man using chenodeoxycholic acid. Lancet 1971; 2: 1213–6.

31.

Thistle

Cleary

Lachin

. The natural history of cholelithiasis: The National Cooperative Gallstone Study. Ann Intern Med 1984; 101: 171–5.

32.

Grundy

Lan

Lachin

. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS). J Clin Invest 1984; 73: 1156–66.

33.

Marks

Baum

Hanson

. Additional chenodiol therapy after partial dissolution of gallstones with two years of treatment. Ann Intern Med 1984; 100: 382–4.

34.

Tangedahl

. The present status of agents for dissolving gallstones. Am J Gastroenterol 1985; 80: 64–6.

35.

Fisher

Anderson

Boyer

. A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis in the National Cooperative Gallstone Study. Hepatology 1982; 2: 187–201.

36.

Corazziari

Pozzessere

Dani

Piccinni-Leopardi

Anzini

Alessandrini

. Chenodeoxycholic acid and diarrhea (letter). Lancet 1978; 2: 266–7.

37.

Albers

Grundy

Cleary

. National Cooperative Gallstone Study—the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology 1982; 82: 638–46.

38.

Tangedahl

Carey

Ferguson

. Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk. Dig Dis Sci 1983; 28: 545–51.

39.

Fisher

Roberts

Rose

. The Sunnybrook Gallstone Study, a double blind controlled trial of chenodeoxycholic acid for gallstone dissolution. Hepatology 1985; 5: 1102–7.

40.

Palmer

Carey

. An optimistic view of the National Cooperative Gallstone Study. N Engl J Med 1982; 306: 1171–4.

41.

Ruppin

Dowling

. Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet 1982; 1: 181–5.

42.

Marks

Lan

Baum

. Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med 1984; 100: 376–81.

43.

Palmer

. More on chenodiol: Continued treatment and prevention of recurrences. Ann Intern Med 1984; 100: 450–1.

44.

Maudgal

Kupfer

Northfield

. Minimum effective dose of chenic acid for gallstone patients: Reduction with bedtime administration and a low cholesterol diet. Gut 1982; 23: 280–4.

45.

Maudgal

Bird

Blackwood

Northfield

. Low cholesterol diet: Enhancement of effect of CDCA in patients with gallstones. Br Med J 1978; 2: 851–3.

46.

McDougal

Yakymyshn

Walker

Thurston

. Effect ot wheat bran on serum lipoproteins and biliary lipids. Can J Surg 1978; 21: 433–5.

47.

Abate

. Medical management of cholesterol gallstones. Drug Intell Clin Pharm 1986; 20: 106–15.

48.

Carey

Tangedahl

. Medical therapy for gallstones. 1. Rationale and indications. Postgrad Med 1982; 71: 163–72.

49.

Heywood

Palmer

Foll

Lee

. Pathological changes in fetal rhesus monkey induced by oral chenodeoxycholic acid (letter). Lancet 1973; 2: 1021.

50.

Benion

Ginsberg

Garnick

Bennett

. Effects of oral contraceptives on the gallbladder of normal women. N Engl J Med 1976; 294: 189–92.

51.

Palmer

. Bile acids, liver injury and liver disease. Arch Intern Med 1972; 103: 106–17.

52.

Maudgal

Bird

Northfield

. Optimal timing of chenic acid in patients with gallstones. Br Med J 1979; 1: 922–3.

53.

Kupfer

Maudgal

Northfield

. Gallstone dissolution rate during chenic acid therapy. Dig Dis Sci 1982; 27: 1025–9.

54.

Benion

Grundy

. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978: 299: 1221–7.

55.

Lee

Melson

Koehler

Stanley

. Cholecystosonography, accuracy, pitfalls and unusual findings. Am J Surg 1980; 139: 223–8.

56.

Drug topics: Annual pharmacists' reference (red book). Oradell, NJ: Medical Economics, Inc., 1987: 192.

57.

Bachrach

Hofmann

. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 1982; 27: 737–61, 833–56.

58.

Igimi

Carey

. Cholesterol gallstone dissolution in bile: Dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate and their glycine and taurine conjugates. J Lipid Res 1981; 22: 254–70.

59.

Hardison

WGM

Grundy

. Effect of ursodeoxycholate and its taurine conjugate on the bile acid synthesis and cholesterol absorption. Gastroenterology 1984; 87: 130–5.

60.

Leiss

Von Bergmann

Stretcher

Strotkoetter

. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology 1984; 87: 144–9.

61.

Nakayama

. Oral cholelitholysis cheno versus urso. Dig Dis Sci 1980; 25: 129–34.

62.

Meredith

Williams

Maton

Murphy

Saxton

Dowling

. Retrospective comparison of cheno and urso in the medical treatment of gallstones. Gut 1982; 23: 382–9.

63.

Tint

Salen

Colalillo

Grable

Berga

Spect

Shefer

. Ursodeoxycholinc acid: A safe and effective agent for dissolving gallstones. Ann Intern Med 1982; 97: 351–6.

64.

Nakano

. Some cases of gallstones dissolved by bile acid preparation. J Natl Counc Commun Hosp 1973; 70: 25–32.

65.

Tokyo Cooperative Gallstone Study Group. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones, a multicenter double blind trial. Gastroenterology 1980; 78: 542–8.

66.

Ward

Brogden

Heel

Speight

Avery

. Ursodeoxycholic acid. A review of its pharmacological properties and therapeutic efficacy. Drugs 1984; 27: 95–131.

67.

Erlinger

Le Go

Husson

Fevery

. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: A double blind randomized, dose-response study and comparison with chenodeoxycholic acid. Hepatology 1984; 4: 308–14.

68.

Fromm

Roat

Gonzales

Sarva

Farivar

. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. Gastroenterology 1983; 85: 1257–64.

69.

Bateson

Bouchier

IAD

Trash

Maudgal

Northfield

. Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br Med J 1981; 283: 645–6.

70.

Neligan

Bateson

Trash

Ross

Bouchier

IAD

. Ursodeoxycholic acid for the dissolution of radiolucent gallbladder stones. Digestion 1983; 28: 225–33.